Delivery Order SPE2DB22D1106-SPE2DB25FFHN1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,171.94 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injections. This competitively awarded, firm fixed-price contract was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and did not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this delivery order,...
- The Defense Logistics Agency awarded a $12,875.92 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injections. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,438.67 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL formulations. This contract, issued on August 22, 2025, with a completion date of August 25, 2025, represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication, valued at $24,255.06. The contract, which was competitively awarded with no set-aside designation, was awarded on August 5, 2025, with a completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, and is priced on a firm fixed-price basis. This delivery order is...
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml injections, with a ceiling value of $44,122.73. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $75,199.20 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a $2,908.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The order, which is scheduled for completion by September 9, 2025, was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a ceiling value of $53,874.20. The contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and utilized firm fixed-price pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,545.48 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, awarded on July 18, 2025, with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHN1Delivery Order
The Defense Logistics Agency (DLA) awarded a $65,172.95 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and was awarded on September 8, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this requirement through its comprehensive federal contract portfolio with DLA and the Defense Health Agency. The underlying IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Ozempic is a diabetes medication within AmerisourceBergen's extensive portfolio of brand-name pharmaceuticals, generic drugs, and specialty medications that support federal medical procurement needs across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.2k | 9/8/25 |